Publications by authors named "C Bouter"

Claim this Profile
L
Long-term thiethylperazine treatment in the Tg4-42 mouse model of Alzheimer's disease mouse: Therapeutic potential vs. adverse effects.
Lisa Katharina Ruoff, Irina Wanda Helene Bänfer, Djavid Elias Liedtke, Sofie Elena China, Jens Wiltfang, Caroline Bouter, Yvonne Bouter

Pharmacol Biochem Behav· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-FDG-PET and Multimodal Biomarker Integration: A Powerful Tool for Alzheimer's Disease Diagnosis.
Yvonne Bouter, Robert M Glasnek, Jannis M Wenzel, Caroline Bouter

Nucl Med Mol Imaging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early stage seronegative autoimmune psychosis.
Imke Amanzada, Caroline Bouter, Dirk Fitzner, Kristina Auf dem Brinke, Berend Malchow

Behav Brain Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship of F-FDG-PET to other common biomarkers of dementia in a clinical cohort with memory deficits.
Katharina Woyk, Niels Hansen, Jens Wiltfang, Claudia Lange, Caroline Bouter

J Alzheimers Dis Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic exposure to a synthetic cannabinoid improves cognition and increases locomotor activity in Tg4-42 Alzheimer's disease mice.
Frederik W Ott, Marius E Sichler, Caroline Bouter, Marzieh Enayati, Jens Wiltfang, Yvonne Bouter

J Alzheimers Dis Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis